Skip to main content
Signal8

Giordano Christopher Thomas

SEC insider (Form 3/4/5 filer). CIK 0001871714. CEO at TENAX THERAPEUTICS, INC. (TENX). 10 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in CHAPEL HILL, NC.

Companies Giordano Christopher Thomas has filed insider reports for

  • TENAX THERAPEUTICS, INC. (TENX): Director, Officer, CEO
Giordano Christopher Thomas profile photo

Giordano Christopher Thomas

CIK: 0001871714

Transaction Breakdown

Open Market Buys (P)5 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (20.0%)

Derivative conversions

Awards (A)3 (30.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TENAX THERAPEUTICS, INC. logo
TENX

TENAX THERAPEUTICS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Sep 15, 2026
    Purchase
    Direct
    4.9K shares at avg. $1.82$9K
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Sep 11, 2026
    Purchase
    Direct
    6K shares at avg. $1.88$11K
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Jul 13, 2026
    Exercise
    Direct
    219 shares at avg. $3.55$777.231
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Jul 13, 2026
    Exercise
    Direct
    8.5K shares at avg. $5.94$50K
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Jan 9, 2026
    Award

    Stock Option (right to buy)

    Direct
    450K shares-
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Nov 20, 2025
    Purchase
    Direct
    538 shares at avg. $7.59$4K
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Nov 19, 2025
    Purchase
    Direct
    455 shares at avg. $7.51$3K
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Nov 18, 2025
    Purchase
    Direct
    1.6K shares at avg. $7.75$13K
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    May 16, 2025
    Award

    Stock Option (right to buy)

    Direct
    1.4M shares-
  • TENAX THERAPEUTICS, INC. logo
    TENX

    TENAX THERAPEUTICS, INC.

    Dec 10, 2024
    Award

    Stock Option (right to buy)

    Direct
    1.3M shares-

1-10 of 10